Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Neoplasms 10Carcinoma, Non-Small-Cell Lung 7Ovarian Neoplasms 6Carcinoma, Transitional Cell 6Squamous Cell Carcinoma of Head and Neck 5Neoplasm Metastasis 5Carcinoma, Renal Cell 5Breast Neoplasms 4Triple Negative Breast Neoplasms 3Recurrence 3Melanoma 3Colorectal Neoplasms 3Urinary Bladder Neoplasms 2Sarcoma 2Lymphoma, Follicular 2Lymphoma 2Central Nervous System Neoplasms 2Uveal Melanoma 1Urethral Neoplasms 1Ureteral Neoplasms 1Solid Tumors 1Skin Neoplasms 1Sezary Syndrome 1Prostatic Neoplasms 1Primary Myelofibrosis 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1Mycosis Fungoides 1Metastatic Urothelial Cell Cancer 1Metastatic Solid Tumors 1

Interventions

Doxorubicin 3ribociclib 1peposertib 1pembrolizumab 1liposomal doxorubicin 1cixutumumab 1avelumab 1Specimen Handling 1Radiotherapy 1Radiation 1Nivolumab 1Magnetic Resonance Spectroscopy 1Imatinib Mesylate 1Histamine H2 Antagonists 1Famotidine 1Cyclophosphamide 1Blood Specimen Collection 1Biopsy 1BO-112 1Angptl4 protein, mouse 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Dermatofibrosarcoma × avelumab × Clear all
NCT04242238 2025-08-28

Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
32 enrolled
Sarcoma

Leiomyosarcoma, Liposarcoma, Sarcoma, Dermatofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡